The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collison, K.
Right arrow Articles by Al-Mohanna, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collison, K.
Right arrow Articles by Al-Mohanna, F.
The Journal of Immunology, 1998, 161: 3737-3745.
Copyright © 1998 by The American Association of Immunologists

Evidence for IL-12-Activated Ca2+ and Tyrosine Signaling Pathways in Human Neutrophils1

Kate Collison, Soad Saleh, Ranjit Parhar, Brian Meyer, Aaron Kwaasi, Khalid Al-Hussein, Sultan Al-Sedairy and Futwan Al-Mohanna2

Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

The cytokine IL-12 is proposed to play a bridging role between innate and adaptive immunity. Here we demonstrate that IL-12 binds specifically to human neutrophils. This binding leads to a transient increase in 1) intracellular free calcium due to its release from membrane-enclosed stores and its influx from extracellular medium, 2) actin polymerization, and 3) tyrosine phosphorylation. IL-12 treatment also leads to a concentration-dependent increase in reactive oxygen metabolite production. The effect of IL-12 is blocked by neutralizing Abs to IL-12. Inhibition of either calcium transient or tyrosine phosphorylation causes inhibition of reactive oxygen metabolite production. However, inhibition of actin polymerization enhances IL-12-induced oxidase activation. Our data suggest 1) a direct role for IL-12 in the activation of human neutrophils, and 2) a calcium-dependent signaling pathway for IL-12.




This article has been cited by other articles:


Home page
Biophys. JHome page
L. F. Olsen, U. Kummer, A. L. Kindzelskii, and H. R. Petty
A Model of the Oscillatory Metabolism of Activated Neutrophils
Biophys. J., January 1, 2003; 84(1): 69 - 81.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. E. A. Portielje, C. H. J. Lamers, W. H. J. Kruit, A. Sparreboom, R. L. H. Bolhuis, G. Stoter, C. Huber, and J. W. Gratama
Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-{gamma}, Tumor Necrosis Factor-{alpha}, IL-6, and IL-8 Responses
Clin. Cancer Res., January 1, 2003; 9(1): 76 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Al-Mohanna, S. Saleh, R. S. Parhar, and K. Collison
IL-12-dependent nuclear factor-{kappa}B activation leads to de novo synthesis and release of IL-8 and TNF-{alpha} in human neutrophils
J. Leukoc. Biol., November 1, 2002; 72(5): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. H. Wyman, C. A. Dinarello, A. Banerjee, F. Gamboni-Robertson, A. A. Hiester, K. M. England, M. Kelher, and C. C. Silliman
Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation
J. Leukoc. Biol., August 1, 2002; 72(2): 401 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. S. Collison, R. S. Parhar, S. S. Saleh, B. F. Meyer, A. A. Kwaasi, M. M. Hammami, A. M. Schmidt, D. M. Stern, and F. A. Al-Mohanna
RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs)
J. Leukoc. Biol., March 1, 2002; 71(3): 433 - 444.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Ethuin, C. Delarche, S. Benslama, M.-A. Gougerot-Pocidalo, L. Jacob, and S. Chollet-Martin
Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils
J. Leukoc. Biol., September 1, 2001; 70(3): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Knight, P. G. Holt, and P. D. Sly
Lipopolysaccharide Inhibits the Late-Phase Response to Allergen by Altering Nitric Oxide Synthase Activity and Interleukin-10
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 640 - 646.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
L. Fantuzzi, P. Puddu, B. Varano, M. Del Cornò, F. Belardelli, and S. Gessani
IFN-{alpha} and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-{gamma} production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages
J. Leukoc. Biol., November 1, 2000; 68(5): 707 - 714.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Di Carlo, A. Comes, S. Basso, A. De Ambrosis, R. Meazza, P. Musiani, K. Moelling, A. Albini, and S. Ferrini
The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement
J. Immunol., September 15, 2000; 165(6): 3111 - 3118.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Nagayama, K. Sato, H. Kawasaki, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, S. Asano, and T. A. Takahashi
IL-12 Responsiveness and Expression of IL-12 Receptor in Human Peripheral Blood Monocyte-Derived Dendritic Cells
J. Immunol., July 1, 2000; 165(1): 59 - 66.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. Gollob, J. W. Mier, K. Veenstra, D. F. McDermott, D. Clancy, M. Clancy, and M. B. Atkins
Phase I Trial of Twice-Weekly Intravenous Interleukin 12 in Patients with Metastatic Renal Cell Cancer or Malignant Melanoma: Ability to Maintain IFN-{{gamma}} Induction Is Associated with Clinical Response
Clin. Cancer Res., May 1, 2000; 6(5): 1678 - 1692.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. I. Simon, Y. Hu, D. Vestweber, and C. W. Smith
Neutrophil Tethering on E-Selectin Activates {beta}2 Integrin Binding to ICAM-1 Through a Mitogen-Activated Protein Kinase Signal Transduction Pathway
J. Immunol., April 15, 2000; 164(8): 4348 - 4358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.